Skip to content

BAY1817080

DRUG12 trials

Sponsors

Bayer

Conditions

Clinical Trials, Phase I as TopicCoughDiabetic Neuropathic PainEndometriosisEndometriosis Related PainHealthy VolunteersNeuropathic Pain Associated With Diabetic Peripheral NeuropathyOveractive Bladder

Phase 1

First in Human Study to Investigate the Safety and Tolerability, Pharmacokinetics, Itraconazole Drug-drug-interaction and Food Effect of BAY1817080
CompletedNCT02817100
BayerClinical Trials, Phase I as Topic
Start: 2016-07-22End: 2017-08-23Updated: 2017-09-06
Repeat Doses of BAY 1817080 in Healthy Males & Proof of Concept in Chronic Cough Patients
CompletedNCT03310645
BayerCough
Start: 2017-12-07End: 2019-06-19Updated: 2023-01-26
Study on the Safety of Drug BAY1817080 at Different Doses and the Way the Body Absorbs and Eliminates the Drug in Japanese Healthy Adult Male Participants
CompletedNCT04265781
BayerDiabetic Neuropathic Pain, Endometriosis Related Pain, Overactive Bladder +1
Start: 2020-02-15End: 2020-09-20Updated: 2023-01-26
Study to Gather Information on the Influence of BAY1817080 on the Electrical Activity of the Heart Recorded by an Electrocardiogram in Healthy Male and Female Participants
CompletedNCT04423744
BayerCough, Endometriosis, Overactive Bladder
Start: 2020-06-18End: 2021-01-21Updated: 2022-01-24
Study on the Safety of BAY1817080, How it is Tolerated and the Way the Body Absorbs, Distributes and Gets Rid of the Study Drug in Participants With Impaired Liver Function or Normal Liver Function
CompletedNCT04454424
BayerDiabetic Neuropathic Pain, Endometriosis Related Pain, Overactive Bladder +1
Start: 2020-07-23End: 2021-12-15Updated: 2023-01-20
Study on the Safety of BAY1817080 How it is Tolerated and the Way the Body Absorbs, Distributes and Gets Rid of the Study Drug Given to Participants With Moderate Renal Impairment and End Stage Renal Disease Requiring Dialysis Compared With Matched Participants With Normal Renal Function
CompletedNCT04471337
BayerDiabetic Neuropathic Pain, Endometriosis Related Pain, Overactive Bladder +1
Start: 2020-08-12End: 2021-05-06Updated: 2024-03-26
A Trial to Learn How a New Liquid Form of BAY1817080 is Tolerated and Taken up by the Body of Healthy Male Participants (Part A). By Labeling BAY1817080 With a Radioactive Substance (Carbon 14) Researchers Want to Learn How the Study Drug is Processed and Excreted by the Body After Dosing (Part B)
CompletedNCT04487431
BayerDiabetic Neuropathic Pain, Endometriosis Related Pain, Overactive Bladder +1
Start: 2020-08-05End: 2021-02-11Updated: 2023-01-26
A Trial to Learn How BAY1817080 Moves Into, Through and Out of the Body and How Safe it is in Healthy Chinese Men
CompletedNCT04802343
BayerHealthy Volunteers
Start: 2021-04-02End: 2021-10-29Updated: 2022-10-19

Phase 2

Related Papers

Therapeutic Advances in Respiratory Disease2021-01-0199 citations